Table 4.
Systolic Blood Pressure (mmHG) | Treated with anti-hypertensive meds
|
Untreated
|
Total
|
|||
---|---|---|---|---|---|---|
PAR | (95% CI)† | PAR | (95% CI)† | PAR | (95% CI)† | |
Prehypertension (120 – <140) | −1.41% | (−6.46%,3.17%) | 19.14 % | (6.54%, 28.81%) | 17.73 | (4.65%, 29.15%) |
Hypertension (≥ 140) | −11.00% | (−27.70%, 5.46%) | 7.94% | (2.40%, 13.23%) | −3.05 | (−20.52%, 14.53%) |
Combined 120 and higher | −12.40% | (−34.68%, 8.57%) | 27.08 % | (8.95%, 42.14%) | 14.68 | (−13.61%, 41.14%) |
Risk estimates are adjusted for confounding factors and competitive risk for death.
1000 bootstrapped 95% CI for all PAR